Replies to post #124300 on Biotech Values

[DewDiligence]

FDA approves Botox for urinary incontinence in patients with MS and other neurological disorders:

http://finance.yahoo.com/news/BOTOX-onabotulinumtoxinA-bw-3923647342.html?x=0&.v=1

AGN will present the detailed data on this indication at an unspecified medical conference.

Botox, which has annualized sales of $1.7B (#msg-65822831), is truly a pipeline within a product. It is approved all over the world for a wide array of medical and cosmetic indications.